Targeted Enzymatic VLP-Nanoreactors with β-Glucocerebrosidase Activity as Potential Enzyme Replacement Therapy for Gaucher's Disease.
Journal Information
Full Title: ChemMedChem
Abbreviation: ChemMedChem
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest The authors declare no conflict of interest."
Funding Disclosure
Evidence found in paper:
"This research was funded by the UC‐Mexico Initiative of the University of California, and by UNAM (PAPIIT IN209722). We thank Dr. Katrin Quester, Itandehui Betanzo, and MSc. Kendra Ramirez for their technical assistance."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025